Recommended Citation
Xiang Yu and Anjan Chatterji,
Why Brand Pharmaceutical Companies Choose to Pay Generics in Settling Patent Disputes: A Systematic Evaluation of Asymmetric Risks in Litigation,
10
Nw. J. Tech. & Intell. Prop.
19
(2011).
https://scholarlycommons.law.northwestern.edu/njtip/vol10/iss2/1